Will GH total company cash burn be below $200M in FY2026?
Current Prediction
Why This Question Matters
Total company cash burn rate determines the funding runway and need for future dilution.
Prediction Distribution
Individual Predictions(9 runs)
Shield commercial launch requires significant sales and marketing investment. Even with core profitability improving, Shield ramp costs may keep total company burn above $200M.
Cash burn reduction requires both revenue growth and expense discipline. Shield commercial ramp inherently requires investment that offsets core profitability gains.
The $200M threshold is meaningful. If core generates $30M positive and Shield costs $250M+, total burn could be $200M+ even with core profitability.
Shield commercial ramp is expensive. Building sales infrastructure, Quest partnership integration, and marketing all consume cash.
Growth companies typically spend more than expected during product launches. Below $200M would be impressive discipline.
Possible if management prioritizes capital efficiency. But Shield success may require more investment, not less.
Below $200M is achievable but challenging during Shield ramp. ~42%.
Growth-stage companies often burn more than targeted. ~40%.
Core profitability helps but Shield investment dominates. ~43%.
Resolution Criteria
Resolves YES if total company net cash burn is below $200M in FY2026. Resolves NO if $200M or more.
Resolution Source
Guardant Health FY2026 cash flow statement
Source Trigger
Funding position rated STRETCHED; cash burn rate determines funding runway and dilution risk
Full multi-lens equity analysis